DYOR. I imagine it's marked price sensitive because it is a significant milestone of an important trial, which is one of several milestones and trials.
- Forums
- ASX - By Stock
- CU6
- Ann: First patient imaged in Phase III AMPLIFY trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
1.62%
!
$2.20

Ann: First patient imaged in Phase III AMPLIFY trial, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.20 |
Change
0.035(1.62%) |
Mkt cap ! $710.1M |
Open | High | Low | Value | Volume |
$2.15 | $2.29 | $2.13 | $3.217M | 1.458M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 12955 | $2.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.20 | 16066 | 36 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 14157 | 2.190 |
14 | 27307 | 2.180 |
11 | 40037 | 2.170 |
12 | 103769 | 2.160 |
8 | 53749 | 2.150 |
Price($) | Vol. | No. |
---|---|---|
2.200 | 13194 | 33 |
2.210 | 24628 | 39 |
2.220 | 9370 | 13 |
2.230 | 20415 | 7 |
2.240 | 48630 | 7 |
Last trade - 15.07pm 16/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |